| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Annoucements
|
|
|
|
22 |
12 |
p. 3652
|
artikel
|
| 2 |
Anticoagulation for splanchnic vein thrombosis in myeloproliferative neoplasms: a systematic review and meta-analysis
|
Chrysafi, Pavlina
|
|
|
22 |
12 |
p. 3479-3489
|
artikel
|
| 3 |
Anxiety in patients with venous thromboembolism: quantification and risk factors in a prospective cohort study
|
Steiner, Daniel
|
|
|
22 |
12 |
p. 3490-3499
|
artikel
|
| 4 |
Assessment of antibodies against platelet factor 4 following vaccination with adenovirus type 26–vectored vaccines
|
Kristyanto, Hendy
|
|
|
22 |
12 |
p. 3532-3541
|
artikel
|
| 5 |
Bivariate genome-wide association study of circulating fibrinogen and C-reactive protein levels
|
Hahn, Julie
|
|
|
22 |
12 |
p. 3448-3459
|
artikel
|
| 6 |
Clinical validation and application of targeted long-range polymerase chain reaction and long-read sequencing–based analysis for hemophilia: experience from a hemophilia treatment center in China
|
Shi, Meizhen
|
|
|
22 |
12 |
p. 3431-3447
|
artikel
|
| 7 |
Development of an assay using a modified coagulation factor V to measure protein S activity
|
Maruyama, Keiko
|
|
|
22 |
12 |
p. 3510-3520
|
artikel
|
| 8 |
Early thrombus formation is required for eccentric and heterogeneous neointimal hyperplasia under disturbed flow
|
Bai, Hualong
|
|
|
22 |
12 |
p. 3614-3628
|
artikel
|
| 9 |
Endothelial colony-forming cells in the spotlight: insights into the pathophysiology of von Willebrand disease and rare bleeding disorders
|
Laan, Sebastiaan N.J.
|
|
|
22 |
12 |
p. 3355-3365
|
artikel
|
| 10 |
Enhanced venous thrombosis and hypercoagulability in murine and human metabolic dysfunction-associated steatohepatitis
|
Pandey, Nilesh
|
|
|
22 |
12 |
p. 3572-3580
|
artikel
|
| 11 |
Estimation of gestational age-specific reference intervals for coagulation assays in a neonatal intensive care unit using real-world data
|
Lalos, Natasha
|
|
|
22 |
12 |
p. 3473-3478
|
artikel
|
| 12 |
Factors associated with venous thromboembolism pharmacoprophylaxis initiation in hospitalized medical patients: the Medical Inpatients Thrombosis and Hemostasis study
|
Repp, Allen B.
|
|
|
22 |
12 |
p. 3521-3531
|
artikel
|
| 13 |
“Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?” Comment from Wada et al
|
Wada, Hideo
|
|
|
22 |
12 |
p. 3647-3649
|
artikel
|
| 14 |
Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study
|
van Kwawegen, Calvin B.
|
|
|
22 |
12 |
p. 3460-3472
|
artikel
|
| 15 |
HMGB1 in platelets: a viable therapeutic target?
|
Vogel, Sebastian
|
|
|
22 |
12 |
p. 3392-3394
|
artikel
|
| 16 |
Incidence and clinical course of chronic thromboembolic pulmonary hypertension with or without a history of venous thromboembolism in Denmark
|
Klok, Frederikus A.
|
|
|
22 |
12 |
p. 3562-3571
|
artikel
|
| 17 |
Interdisciplinarity within thrombosis and hemostasis: opportunities for early career professionals to find their niche
|
Sewaralthahab, Sarah
|
|
|
22 |
12 |
p. 3333-3335
|
artikel
|
| 18 |
Intron 22 inversions: cross-reactive material or no cross-reactive material?
|
Doshi, Bhavya S.
|
|
|
22 |
12 |
p. 3400-3402
|
artikel
|
| 19 |
Issue Information
|
|
|
|
22 |
12 |
p. e1-e5
|
artikel
|
| 20 |
JTH in Clinic: management of low-risk pulmonary embolism
|
Han, Henry
|
|
|
22 |
12 |
p. 3406-3414
|
artikel
|
| 21 |
Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk
|
Vir, Pooja
|
|
|
22 |
12 |
p. 3415-3430
|
artikel
|
| 22 |
Low von Willebrand factor—unraveling an enigma wrapped in a conundrum
|
O’Donnell, James S.
|
|
|
22 |
12 |
p. 3383-3388
|
artikel
|
| 23 |
Meta-analyzing antithrombotic therapy in myeloproliferative neoplasm–related splanchnic vein thrombosis: a first step in understanding a rare complication of a rare disease
|
Tremblay, Douglas
|
|
|
22 |
12 |
p. 3395-3396
|
artikel
|
| 24 |
Paclitaxel improves thrombopoiesis in the absence of thrombopoietin receptor (Mpl)
|
Meng, Panpan
|
|
|
22 |
12 |
p. 3599-3613
|
artikel
|
| 25 |
Patency and reflux in relation to postthrombotic syndrome: a subanalysis of the Ultrasound-Accelerated Catheter-Directed Thrombolysis Versus Anticoagulation for the Prevention of Post-Thrombotic Syndrome trial
|
Hupperetz, Ruben D.
|
|
|
22 |
12 |
p. 3552-3561
|
artikel
|
| 26 |
Platelet HMGB1 steers intravascular immunity and thrombosis
|
Maugeri, Norma
|
|
|
22 |
12 |
p. 3336-3345
|
artikel
|
| 27 |
Professor Victor S. Blanchette, MA, MB, BChir (Cantab), FRCP(C), FRCP (1945-2024)
|
Rand, Margaret L.
|
|
|
22 |
12 |
p. 3650-3651
|
artikel
|
| 28 |
Reply to the comments on “Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?” from Wada et al.
|
Iba, Toshiaki
|
|
|
22 |
12 |
p. 3645-3646
|
artikel
|
| 29 |
Resistance to tPA-induced fibrinolysis and activation of coagulation is present in autoimmune bullous diseases of the skin
|
Sharma, Divya
|
|
|
22 |
12 |
p. 3640-3644
|
artikel
|
| 30 |
RUNX1 isoforms regulate RUNX1 and target genes differentially in platelets-megakaryocytes: association with clinical cardiovascular events
|
Guan, Liying
|
|
|
22 |
12 |
p. 3581-3598
|
artikel
|
| 31 |
Shifting focus from venous to arterial thromboembolism in patients with cancer
|
Strijdhorst, Anniek
|
|
|
22 |
12 |
p. 3403-3405
|
artikel
|
| 32 |
The changing face of cerebral venous sinus thrombosis—emerging new causes and treatments
|
Dix, Caroline
|
|
|
22 |
12 |
p. 3346-3354
|
artikel
|
| 33 |
The eccentric nature of the neointima
|
Stoyell-Conti, Filipe F.
|
|
|
22 |
12 |
p. 3397-3399
|
artikel
|
| 34 |
The evolving landscape of von Willebrand disease diagnosis
|
Sadler, Brooke
|
|
|
22 |
12 |
p. 3389-3391
|
artikel
|
| 35 |
The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia
|
La Mura, Vincenzo
|
|
|
22 |
12 |
p. 3629-3639
|
artikel
|
| 36 |
Treatment of atrial fibrillation and venous thromboembolism with factor Xa inhibitors in severely obese patients
|
Dobry, Paul
|
|
|
22 |
12 |
p. 3500-3509
|
artikel
|
| 37 |
Utility of the modified Ottawa score for identification of more preferable candidates of extended anticoagulation therapy in cancer-associated isolated distal deep vein thrombosis: insight from the ONCO DVT Study
|
Xiong, Wei
|
|
|
22 |
12 |
p. 3542-3551
|
artikel
|
| 38 |
Viral coagulation: pushing the envelope
|
George Pryzdial, Edward Louis
|
|
|
22 |
12 |
p. 3366-3382
|
artikel
|
Tijdschrift beschrijving